Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 6 (2006), Pages 1642-1655
http://dx.doi.org/10.1100/tsw.2006.263
Mini-Review Article

Amylin in the Periphery II: An Updated Mini-Review

1Department of Medicine, University of Melbourne, Austin Health, Repatriation Campus, Heidelberg Heights, Vic., Australia
2Institute of Veterinary Physiology Zurich Center for Integrative Human Physiology, University of Zurich, Switzerland

Copyright © 2006 Peter J. Wookey et al.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • R. M. Martinez-Alvarez, H. Volkoff, J. A. Munoz Cueto, and M. J. Delgado, “Molecular characterization of calcitonin gene-related peptide (CGRP) related peptides (CGRP, amylin, adrenomedullin and adrenomedullin-2/intermedin) in goldfish (Carassius auratus): Cloning and distribution,” Peptides, vol. 29, no. 9, pp. 1534–1543, 2008. View at Publisher · View at Google Scholar
  • Cornelia B. Landersdorfer, and William J. Jusko, “Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus,” Clinical Pharmacokinetics, vol. 47, no. 7, pp. 417–448, 2008. View at Publisher · View at Google Scholar
  • Matthew Potenza, and Elliot J. Rayfield, “Targeting Incretins in Type 2 Diabetes Mellitus,” Mount Sinai Journal of Medicine, vol. 76, no. 3, pp. 244–256, 2009. View at Publisher · View at Google Scholar
  • Arpád Dobolyi, “Central amylin expression and its induction in rat dams,” Journal of Neurochemistry, vol. 111, no. 6, pp. 1490–1500, 2009. View at Publisher · View at Google Scholar
  • Joseph J. Gingell, Tao Qi, Richard J. Bailey, and Debbie L. Hay, “A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor,” Peptides, vol. 31, no. 7, pp. 1400–1404, 2010. View at Publisher · View at Google Scholar
  • Summer James, Jennifer Moralez, and Manubai Nagamani, “Increased secretion of amylin in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 94, no. 1, pp. 211–215, 2010. View at Publisher · View at Google Scholar
  • Thomas A. Lutz, “The role of amylin in the control of energy homeostasis,” American Journal of Physiology-Regulatory Integrative and Comparative Physi, vol. 298, no. 6, pp. R1475–R1484, 2010. View at Publisher · View at Google Scholar
  • Deborah L. Young-Hyman, and Catherine L. Davis, “Disordered Eating Behavior in Individuals With Diabetes Importance of context, evaluation, and classification,” Diabetes Care, vol. 33, no. 3, pp. 683–689, 2010. View at Publisher · View at Google Scholar
  • Vera Brekhman, Jennie Lugassie, Shelly Zaffryar-Eilot, Edmond Sabo, Ofra Kessler, Victoria Smith, Hana Golding, and Gera Neufeld, “Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2,” Faseb Journal, vol. 25, no. 1, pp. 55–65, 2011. View at Publisher · View at Google Scholar
  • Ruchi Gupta, Neeraj Kapoor, Daniel P. Raleigh, and Thomas P. Sakmar, “Nucleobindin 1 Caps Human Islet Amyloid Polypeptide Protofibrils to Prevent Amyloid Fibril Formation,” Journal of Molecular Biology, vol. 421, no. 2-3, pp. 378–389, 2012. View at Publisher · View at Google Scholar
  • Herbert F. Helander, and Lars Fandriks, “The enteroendocrine "letter cells" - time for a new nomenclature?,” Scandinavian Journal of Gastroenterology, vol. 47, no. 1, pp. 3–12, 2012. View at Publisher · View at Google Scholar
  • Patrizia D. Amelio, Anna Panico, Elena Spertino, and Giovanni Carlo Isaia, “Energy metabolism and the skeleton: Reciprocal interplay,” World Journal of Orthopaedics, vol. 3, no. 11, pp. 190–198, 2012. View at Publisher · View at Google Scholar
  • Y. von Hausswolff-Juhlin, S. J. Brooks, and M. Larsson, “The neurobiology of eating disorders-a clinical perspective,” Acta Psychiatrica Scandinavica, 2014. View at Publisher · View at Google Scholar
  • Montse Visa, Gema Alcarraz-Vizan, Joel Montane, Lisa Cadavez, Carlos Castano, Maria Luisa Villanueva-Penacarrillo, Joan-Marc Servitja, and Anna Novials, “Islet amyloid polypeptide exerts a novel autocrine action in beta-cell signaling and proliferation,” Faseb Journal, vol. 29, no. 7, pp. 2970–2979, 2015. View at Publisher · View at Google Scholar
  • Laura Hieronymus, and Stacy Griffin, “Role of Amylin in Type 1 and Type 2 Diabetes,” Diabetes Educator, vol. 41, pp. 47S–56S, 2015. View at Publisher · View at Google Scholar
  • Hye Rin Jeong, and Seong Soo A. An, “Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus,” Clinical Interventions In Aging, vol. 10, pp. 1873–1879, 2015. View at Publisher · View at Google Scholar
  • Ivana Sequeira, and Sally Poppitt, “Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP),” Nutrients, vol. 9, no. 7, pp. 788, 2017. View at Publisher · View at Google Scholar
  • Xinghuo Wu, Kun Wang, Wenbin Hua, Shuai Li, Xianzhe Liu, Wei Liu, Yu Song, Yukun Zhang, Zengwu Shao, and Cao Yang, “Down-regulation of islet amyloid polypeptide expression induces death of human annulus fibrosus cells via mitochondrial and death receptor pathways,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017. View at Publisher · View at Google Scholar
  • Yun Zhang, and Weihong Song, “Islet Amyloid Polypeptide: Another Key Molecule in Alzheimer’s Pathogenesis?,” Progress in Neurobiology, 2017. View at Publisher · View at Google Scholar
  • Bing Fang, Jin Wang Li, Ming Zhang, Fa Zheng Ren, and Guo Fang Pang, “Chronic chlorpyrifos exposure elicits diet-specific effects on metabolism and the gut microbiome in rats,” Food and Chemical Toxicology, 2017. View at Publisher · View at Google Scholar